Molecular diagnostics startup Abcodia is collaborating with Oxford Gene Technology to discover and validate biomarkers for early detection of pancreatic cancer. Abcodia has a serum biobank including samples from people with pancreatic cancer from up to 7 years before diagnosis, and will use data mining to select sets of samples. Oxford Gene Technology will then screen these samples using its functional protein array platform and Genefficiency microRNA profiling array to identify biomarkers specific to pancreatic cancer. Release